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Abstract
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Systemic sclerosis (SSc) is a heterogeneous multisystem autoimmune disease whereby its main
pathological drivers of disability and damage are vascular injury, inflammatory cell infiltration,
and fibrosis. These mechanisms result in diffuse and diverse impairments arising from ischemic
circulatory dysfunction leading to painful skin ulceration and calcinosis, neurovascular aberrations
hindering gastrointestinal (GI) motility, progressive painful, incapacitating or immobilizing effects
of inflammatory and fibrotic effects on the lungs, skin, articular and periarticular structures, and
muscle. SSc-related impairments impede routine activities of daily living (ADLs) and disrupt three
critical life areas: work, family, social/leisure, and also impact on psychological well-being.
Physical activity and exercise are globally recommended; however, for connective tissue diseases,
this guidance carries greater impact on inflammatory disease manifestations, recovery, and
cardiovascular health. Exercise, through myogenic and vascular phenomena, naturally targets key
pathogenic drivers by downregulating multiple inflammatory and fibrotic pathways in serum and
tissue, while increasing circulation and vascular repair.

Author Manuscript

G-FoRSS, The Global Fellowship on Rehabilitation and Exercise in Systemic Sclerosis recognizes
the scientific basis of and advocates for education and research of exercise as a systemic
and targeted SSc disease-modifying treatment. An overview of biophysiological mechanisms of
physical activity and exercise are herein imparted for patients, clinicians, and researchers, and
applied to SSc disease mechanisms, manifestations, and impairment. A preliminary guidance on
exercise in SSc, a research agenda, and the current state of research and outcome measures are set
forth.
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Introduction
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Systemic sclerosis (SSc) is a heterogeneous multisystem autoimmune disease with
main pathological drivers of disability/damage being vascular injury, inflammatory cell
infiltration, and fibrosis [1]. Skin thickening varies widely and its distribution creates
a rudimentary subtyping: sine scleroderma (without skin thickening), limited cutaneous
(lcSSc) (skin thickening of face and distal to elbows/knees), and diffuse cutaneous
(dcSSc) (includes proximal skin thickening above elbows/knees) [2]. However, systemic
manifestations are the true hallmark of SSc. Sine and lcSSc have more vasculopathic
tendencies; but any SSc manifestation occurs in all subtypes, and all subtypes being
potentially lethal and associated with severe and multiple disabilities [2–5].

Author Manuscript

In SSc, physical function, a predictor of health-related quality of life (HRQoL) and
survival can be severely diminished by diffuse, diverse impairments arising from ischemic
circulatory dysfunction (leading to painful skin ulceration and calcinosis, to neurovascular
aberrations hindering gastrointestinal (GI) motility), to progressive painful, incapacitating or
immobilizing effects of inflammatory and fibrotic effects on the lungs, skin, articular, and
periarticular structures and muscle [4,5]. SSc-related impairments impede routine activities
of daily living (ADLs), disrupt critical life areas: work, family, social/leisure, and also
deteriorate psychological well-being [6,7].

Author Manuscript

Despite physical activity being vital to general health, muscle function, physical
function, and aerobic capacity; attention to these cornerstone therapeutic concepts are
often overshadowed by patients/clinicians feeling overwhelmed by other SSc medical
management or fearful of overexertion [8,9]. Exercise, through myogenic and vascular
phenomena, naturally targets key SSc pathogenic drivers by downregulating multiple
inflammatory and fibrotic pathways [10,11] in serum and tissue [12,13] while increasing
circulation and vascular repair. Based on evidence in SSc and other connective tissue
diseases (CTDs), patients with SSc can benefit from exercise through reduced disease
activity, systemic inflammation, pain and fatigue as well as improved muscle function, joint
and bone strength, aerobic capacity/cardiopulmonary function, and HRQoL [14]. While
SSc notoriously erodes body image, physical activity is elemental to embodiment practices,
allays biochemical impact on depression/anxiety, stress, and physical pain burden, and
improves self-esteem [15–18]. Myogenic and vascular mechanisms likely contribute to
exercise’s beneficial impact on sleep, pain, fatigue, and GI health and gut flora [19,20].
As a global collaborative, relying on scientific evidence and expert experience of developing
exercise programs in SSc and other serious health conditions, we describe the current
state of exercise as it relates to SSc disability and disease activity. We propose strategies
targeting pathological SSc disease mechanisms and manifestations with the goal of reducing
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disease activity and optimizing physical function that include supervised-, home-, land-,
water-based, pulmonary rehabilitative exercise, and newer evidence-based technologies [15–
18,21–44]. Future research priorities in SSc rehabilitation medicine are highlighted.

Physical activity and exercise as medicine
Physical activity encompasses any bodily movement by skeletal muscle requiring energy
expenditure above resting levels [45,46]. Exercise, a subset of physical activity, is
planned, structured, repeated, and targets improvement or maintenance of physical fitness,
performance, or health. “Physical activity/exercise,” herein refers to all the following:
workouts, training, rehabilitation, physical therapy, including modalities such as martial
arts, singing, yoga, and dance for which growing evidence supports improved articular and
respiratory health [45].

Author Manuscript

A physically active lifestyle is essential for health, with higher aerobic fitness being strongly
associated with the absence of disease [47]. Recommendations to improve muscle strength/
endurance and aerobic capacity define exercise type and dosing (frequency, duration, and
intensity) (Fig. 1 and Tables 1–4) [48–51], which correspond to health benefits, e.g., in
obesity, type II diabetes, hypertension, cardiovascular disease (CVD), some forms of cancer
[46,52], and in CTDs associated with increased risk of CVD, such as SSc. Exercise benefits
extend to muscle, bone density, nerve and joint health, HRQoL, sleep quality, and mental
health – areas that are more highly impacted in CTDs; while physical inactivity rapidly
erodes these benefits.

Author Manuscript

A phenomenal rate of emerging evidence points toward muscle and muscle contraction
being pivotal and pervasive on vital pan-systemic function (Fig. 2). The muscle’s paracrine,
endocrine, and cytokine regulation across multiple systems (brain, skin, cardiovascular,
vascular, gastrointestinal, osseous, immunological, endocrine, and pulmonary), is
increasingly prompting the consideration of muscle as an endocrine organ beyond and its
roles of motility/mobility [12–14,19,33,45–47,50,53–60].

Author Manuscript

Longstanding inflammation in CTDs heightens CVD event risk, bone and muscle loss,
pain, stiffness, poor sleep, and fatigue predisposing to further inactivity and muscle
disuse. Aerobic and resistance training reduce ESR and CRP in several CTDs [61,62]
with improvement in fatigue, pain, and stiffness. Muscle contraction activates multimodal
cascades through mechanical and chemical mechanisms that systemically downregulates
circulating and tissue inflammation while upregulating vascular support and repair that
activate an anti-inflammatory cascade - thus interrupting this vicious inflammatory cycle
[54]. Exercise mechanisms are numerous with instantaneous and lasting inflammatory
transformations e.g., myriad myokine circuits through e.g., IL-6, IL-1, IL-10, IL-15,
FSTL-1, etc., muscle-fat mass distribution impacting adipokine-inflammasome dynamics,
mediate long-term reduced risk of cardiovascular disease [12,13,57], and endothelial
function and repair [55–57] – a crucial dysfunctional pathway of SSc pathology.
A growing body of evidence supports the safety and efficacy of exercise in systemic
inflammatory conditions such as myositis, rheumatoid arthritis (RA), and systemic lupus
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erythematosus (SLE) with fatigue and depression reduction [61,62]. In myositis, exercise
effects include: a) upregulation of anti-inflammatory genes and genes related to muscle
growth and vascularization, with downregulation of proinflammatory genes and fibrosis; b)
increased capillary density in the muscle tissue along with improved mitochondrial enzyme
function [58,63–65]; and c) the prevention of mitochondrial damage and myofiber apoptosis
through exercise-induced reduction of myositis-related Harakiri and TLR7 expression
[58,66]. We submit that these clinical and preclinical exercise effects on inflammation
and vascular repair and function also occur in SSc and could favorably impact disease
manifestations related to these drivers.

Author Manuscript

Direct and indirect costs related to SSc and other CTDs are significant with reduced labor
productivity that results in striking losses [67]. Physical inactivity contributes significantly
to overall SSc disease burden [67–71] with exercise being a potent antidote improving
function and potentially diminishing disease-related economic burden. Exercise intervention
has demonstrated a cost benefit in other conditions such as pulmonary hypertension (PH)
and RA, when compared with medical treatment alone [72–74]. Evidence suggests analyses
of exercise-related economic benefit in SSc and other CTDs are warranted [72–74].

Disease mechanisms in SSc treatment paradigms
Autoimmunity, inflammation, vasculopathy, and fibrosis in SSc

Author Manuscript

Inflammation is the hallmark of many autoimmune diseases which includes SSc. Unless
halted, ongoing inflammation spurs further proinflammatory pathways and recruitment
of immune cells that assault host tissue with histotoxic infiltrates, which result in tissue
damage. Inflammation can be rapidly or slowly progressive or even punctuated by periods of
inactivity. Quieting inflammation may decelerate disease progression and reduce symptoms.
Ongoing inflammatory mechanisms trigger downstream pathways that lead to fibrosis, the
final transition from reversible inflammation to permanent damage.
Diffuse vascular/endothelial injury, dysfunction, and disrepair occur in SSc. However, it
is yet unclear if interruption of the inflammatory/autoimmune – fibrosis trajectory with
pharmaceuticals also deters progressive vascular disease. If so, exercise hypothetically
targets vascular SSc manifestations through both anti-inflammatory/anti-fibrosis and
circulation mechanisms, including mitigating the endothelial shear stress of SSc
vasculopathy [75,76] (Table 5).

Treatment in the context of the inflammation-fibrosis trajectory and
Author Manuscript

circulation
SSc symptoms and impairments can result from currently active drivers of disease, which
may recede with systemic treatment or from tissue damage that remains after the resolution
of active disease. Ideally, SSc is pharmacologically treated in the inflammatory predominant,
more reversible early stages to prevent permanent disability. Less ideal, but still important,
is salvaging functional tissue by reversing resident inflammation in areas of coexistent
fibrotic damage to prevent further fibrotic damage-related disability. SSc progression
can span widely between rapidly progressive (robust inflammatory driver) or indolently
Best Pract Res Clin Rheumatol. Author manuscript; available in PMC 2022 September 01.
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progressive (subtle inflammatory driver) transformation to fibrosis. Newer antifibrotic
medications decelerate fibrosis-transforming pathways, but are unable to reverse end fibrosis
or significantly reduce inflammation.

Patient-reported experience and perceptions of exercise
Successful patient engagement requires respectful understanding of hopes, fears, needs,
experiences, perceptions, priorities, and barriers of an intervention from the perspective
of the targeted population. Limited yet substantive work investigate patients’ perspective
of exercise on SSc-related manifestations [77–80] with diverse impairments reported
in physical capacity, which includes reduced muscle strength, impaired mobility,
cardiopulmonary problems [78], substantial diseaserelated economic burden, and poor
HRQoL [81,82].

Author Manuscript

Participants consistently expressed hopeful perceptions, “The more I exercise, the more
improved my health and the chance to survive longer …. ” Inactivity was consistently
connected with further decline in health status: “… because of my lung disease … I’ve
been close to death a couple of times, so I notice a big difference between exercising and
not exercising. It’s as different as night and day.” [77] However, despite perceiving exercise
as essential for life and health [77], patients also report not engaging in exercise [77,78].
Multifactorial demotivators include: a) manifestation-related e.g., digital ulcers (DUs), joint
pain, and restricted motion; b) constitutional effects of disease e.g., pain and fatigue; c)
psychosocial struggles of living with SSc d) fear and lack of exercise safety knowledge, and
e) logistical burden of preparation and participation [77].

Author Manuscript

Patient self-knowledge and experience provide a roadmap for researchers to understand
both cohort and individually targeted interventions. In separate studies, patient report
corroborated by physiotherapist assessment with markedly reduced muscle endurance in
shoulder and hip flexion as well as reduced lower extremity strength [83]. Fatigue,
Raynaud’s phenomenon (RP), physical limitations, joint problems, and DUs persist as
unmet needs in SSc care [77,80,84,85], though each is potentially modifiable by exercise
[77]. SSc symptoms, such as pain, fatigue, breathlessness, and impaired hand function,
influence self-rated work ability and employment status [86–89]. Raising awareness of SSc
related work impediments, such as these, may identify interventions for physical function
that provide a path to diminish economic burden [77] and improve perceived well-being
[89].

Author Manuscript

Patients report major exercise benefits being improved blood circulation particularly in
hands, feet, and prolonged core-warming, breathing, fatigue, pain, sleep, vitality and
musculoskeletal function [77]. Whether exercise exerts an effect on socially stigmatizing
disease-related barriers, such as DUs [77,90] or body dissatisfaction, deserves investigative
attention.
Patients conveyed that planning, adaptation, and post-exercise recovery time were important
considerations particularly with severe lung disease or after vigorous exercise [77].
Patients report adapting intensity and activity type to facilitate exercise during inclement
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weather or increased symptoms. Furthermore, patients conveyed that healthcare professional
counselling on exercise instruction, benefits, and cautions might be helpful, particularly
early in the disease [77].
Though an SSc-specific patient-reported experience measure remains to be developed
[91,92], a patient activation measure [93] assessing levels of disease knowledge, motivation,
and support can be used to facilitate patient engagement in exercise protocols.

SSc manifestations and physical activity/exercise
The following section outlines the current state of exercise safety, efficacy, and assessment
crossed with SSc symptoms and manifestations (Tables 6–10 and Fig. 3). It is not exhaustive
nor comprehensive in potential benefits nor in the science that predicts the ability of exercise
to prevent disease progression and disability in SSc.

Author Manuscript
Author Manuscript

Cardiopulmonary Involvement in SSc: is common with pulmonary parenchymal
involvement/interstitial lung disease (ILD) being the leading cause of SSc death,
followed by pulmonary vascular involvement/PH. Cylindrical bronchiectasis and severe
esophageal reflux may also affect airways in SSc [94]. Cardiac decompensation may
occur secondary to SSc pulmonary manifestations, pericardial disease, or malignant
hypertension (renal crisis); however, primary SSc-cardiac manifestations can arise from
muscle, microvascular, and neuronal dysfunction [95]. Resultant clinical correlates of
cardiac involvement in SSc include diastolic dysfunction from either myofibrosis or
microcirculatory insufficiency, dilated cardiomyopathy, or arrhythmias. Breathlessness is a
common feature of cardiopulmonary manifestations of SSc, along with exercise intolerance,
diminished HRQoL, and occasionally pleural or pericardial pain [96–98]. In ILD, a
disabling inspiratory cough can exacerbate breathlessness [99]. In early stages, symptoms
may be mild, and by unconsciously restricting or slowing activity levels many patients do
not recognize early symptoms. Musculoskeletal impairments restricting activity also make
the recognition of cardiopulmonary limitations less apparent.

Author Manuscript

Aerobic and muscle-strengthening exercises significantly improve [100] HRQoL as well
as cardiovascular, endothelial, metabolic/glandular, muscle structure and function, lung
mechanics, mobility, and systemic inflammation [95,100–103] with overall positive effect
on the physiological and psychological components [101,104–106]. Exercise cultivates a
fitness that can offset cardiopulmonary deficiency by facilitating greater ease, capacity,
and reserve as patients interface with life activities [6]. For example, exercise promotes
stronger, more supple, and neurologically responsive feet, important for efficient rising,
balancing, propelling, and mobilizing the body. Diaphragmatic strengthening fortifies
respiratory dynamics and improves attributes that support respiratory capacity, e.g., balance,
core strength, and lower back health [107–109]. As intercostal and accessory muscles
achieve improved postural strength and flexibility, increasingly easier bending, reaching, and
twisting during activities is possible with less breathlessness. Furthermore, exercise practices
movement coordinated with breath, thus increasing skilled capacity for complex, weighty, or
increasingly intense activities. Strategies such as Singing for Lung Health [30,35,110–114],
yogic breathing, Tai Ch’i [115,116] as well as some yoga and dance techniques, support
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healthier breath patterns and efficiency, e.g., abdominal relaxation increasing inspiratory
capacity, stronger and efficient oral musculature, etc.

Author Manuscript

Pulmonary rehabilitation is supported as feasible, safe, and effective [117,118] regardless
of underlying diagnosis (e.g., ILD and PH) and can improve breathing, exercise
tolerance, fatigue, and cough [119]. Exercise safety in SSc-cardiopulmonary involvement
[79,120–123] are outlined in Tables 7a and 7b, Tables 8–10 as are programmatic
considerations and enhancements [105,106,121]. Cardiopulmonary-related breathlessness
carries neurophysiological, cognitive, and emotional distress different from other exertional
breathlessness [16,29,124]. Worries over breathlessness and what breathlessness might
signify hinders exercise. Patient-clinician discussions are key to successful, confident
engagement in exercise [16,99,124,125]. Patients require reassurance that breathlessness
and desaturation are distinct attributes often independent of each other. Desaturation is a
chemical phenomenon, while breathlessness is a complex multifactorial, multidimensional
experience, and of itself is not physiologically harmful [124]. We explain the following to
patients who feel frightened or frustrated: “Being physically unfit causes breathlessness and
fatigue,” “Exercise treats unfitness, exercise also causes breathlessness, but can be done in
non-distressing manners that will diminish breathlessness over time.”
Along these lines, patients with underlying cardiopulmonary conditions, may be at a
higher risk of dysfunctional breathing patterns such as hyperventilating or breath-holding,
which contribute toward additional neurophysiological mechanisms related to breathlessness
sensations [126]. Breathing pattern disorders can be rehabituated to healthier breathing
patterns with practiced breath regulation that is strengthened by exercise.

Author Manuscript

Gastrointestinal Tract in SSc: is the most common internal organ involved in SSc,
which affects >90% of patients with SSc. SSc can impair function from mouth to anus,
hypothetically by the same vicious cycle of inflammation, vascular insufficiency and leak,
immune dysfunction, and disrepair [127] as other organ systems. Myomucosal fibrotic
infiltration and neuronal rarefaction results in damage, which include salivary glandular
dysfunction, pan- or partial-GI dysmotility, and loss of GI sphincter muscle tone and
dysmotility. Symptoms from these pathological processes include difficulty with ingesting
food and mastication, acid reflux predisposing to esophagitis, dysphagia, esophageal
stricture and malignancy, bloating, cramping, early satiety, nausea, emesis, regurgitation,
constipation, bacterial overgrowth, diarrhea, fecal leakage or frank incontinence, and
malnutrition. Symptoms should be managed early and aggressively [4,128,129]. GI
symptoms severely diminish HRQoL greatly interfering with life participation [130] and
potentially resulting in depression [131,132] and self-imposed isolation.

Author Manuscript

Though not expressly intuitive, exercise impacts GI function and symptoms via multimodal
mechanisms [133–137]. Mouth exercise and physical activity correlate with improved
salivation, oral health, and function [133,137]. Even minor physical activity such as walking
stimulates digestion, reduces nausea, and promotes motility. Physical activity is linked to
decreasing digestive system cancers, decreasing proinflammatory gut microbiota, and gut
restoration of health-promoting microbiota resulting also in favorable effects on cognition
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and mental health [19,138–141]. Microbiome restoration could be a key influencer of lower
GI health [20] as dysbiosis appears to be a feature of the SSc disease state [142–144].
In exercise, the large diaphragmatic muscle draws downward for chest expansion and lung
aeration, exerting rhythmic mechanical massaging forces on the abdominal cavity contents;
also creating pronounced intra-abdominal pressure differentials stimulating neuronal
networks and parasympathetic action. These actions assist in GI motility and function and
in reducing symptoms e.g., nausea, bloating, and constipation. Singing, chanting, martial
arts, and yogic breathwork emphasize these actions; but all exercise potentially encourages
synchronized breathwork that benefit GI health.
Online home-based exercise platforms are increasingly available, particularly for patients
uncomfortable travelling due to diarrhea or fecal soilage.

Author Manuscript

Face Involvement in SSc: can change in appearance from the tightening and fibrous
transformation of facial skin, mask-like (mauskopf) appearance, and perioral wrinkling
with retracting lip-thinning and hollowed appearance of the cheeks. The changes can have
devastating effects on body image, self-esteem, and well-being [145,146]. A mix of manual
techniques and home exercise had a positive effect on mouth opening as compared to
only home exercise [147]. Though the impact of facial exercises on self-esteem has not
been directly examined, exercise leads to increased self-esteem and feelings of well-being
[77,100,148]. Application of sauna techniques to optimize exercise is yet unstudied. In
addition to optimizing breath, diaphragmatic strength, and GI dynamics, singing may have
similar impact on oral/facial musculature, salivation, and circulation [133,137].
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Mouth Involvement in SSc: can impair mouth opening, often noticed during dental
examinations, oral care, eating and chewing [149]. The fibrous transformation of the facial
skin, muscles, lips, and palatal structures with teeth shifting can lead to multiple oral
problems such as reduced oral aperture, decreased salivary production, and increase in
dental caries, pain with chewing, and tooth loss. Oral care requires heightened attention from
diagnosis throughout the disease course. Oral stretching along with facial exercises [147]
and massage have been shown to increase mouth opening with possible other structural,
vascular, and glandular benefits and sometimes lead to better oral health [150,151].
Skin in SSc: portends diffuse functional impairment to the body beyond anatomical
restriction. SSc disrupts the skin’s superficial and deep architecture of sweat and sebaceous
glands, nerves, and blood vessels with biochemical, hormonal, glandular, neurological,
immune, circulatory and thermoregulatory, and wound-healing dysfunction [152].
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Exercise and manual manipulation increases blood flow to the skin, which provides
nourishment, oxygenation, toxin removal, and warmth; muscle activity stimulates
mitochondrial function in the skin essential for wound healing [8,153,154]. Exercise hastens
lymphatic drainage of edema [147], important in early diffuse disease. Exercise increases
circulation and sweating in those able to still sweat. Sweat facilitates toxin and inflammatory
cytokine release through the skin.
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Hands in SSc: are particularly subject to diffuse morphological changes, impairment, and
pain due to inflammatory assault, vascular insufficiency and injury, and fibrous infiltration
and damage. These pathological processes may result in infection, ulceration, calcinosis,
acro-osteolysis, flexion contractures, carpal tunnel syndrome, cold sensitivity and RP,
synovitis, tendinopathy, and amputation [155].
Hand and wrist impairment impacts remunerative and household work, self-care, nutrition,
and the handling of exercise equipment. DUs and calcinosis are described as not only
painful but also socially stigmatizing during exercise due to visible lesions or the need for
bandages and/or gloves for hand protection [77]. Certified hand therapists/OTs can address
hand strength, mobility, and contractures; and provide tools for improvement in self-care and
work capacity.
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The role of hand exercises in SSc cannot be overstated. The hands are often involved early
and rapidly lose range of motion (ROM) and strength. Encouraging home-based “ritualised”
practice has multiple benefits [156–158]. Exercise supports circulation [100], healthy
vasculature, skin repair, and warmth - important factors in RP, DUs, and calcinosis. Exercise
increases hand/wrist muscle strength and efficiency, adding to the already intrinsic benefits
on local inflammation, stiffness, and joint lubrication [150,151]. Preventive strategies to
maintain hand warmth and adjuvant, preparatory strategies described below, such as paraffin,
sauna, and water-based exercise, optimize tolerability and outcomes [156,159]. Exercise
gloves may improve handgrip when performing muscle strengthening exercises, particularly
when handling/gripping cold metal. Grip and hand placement techniques can also be
modified to enable the performance of particular exercises [77]. Assessment of hand/arm
function at baseline and intervals (Table 9) can provide direction and encouragement [160–
175].
Feet in SSc: often receive little attention although patients experience significant SSc
related challenges, including RP, ischemic injury, contractures, plantar rigidity, fat pad
atrophy, and pain with impact on gait ability and pattern [77], comfort, balance, and other
domains of mobility [176,177]. Furthermore, compromised strength of the lower extremity
musculature and decreased ankle motion may create higher risk for falls [178]. Pedal soft
tissue damage/loss renders standing and exercising painful for some patients, making good
footwear or orthotic insoles an important consideration.

Author Manuscript

Developing strong supple, responsive feet and ankles through exercise and physical activity
increases pedal circulation and improves performance efficiency of body mobility (rising,
stairs, and walking) and balance. These are all important factors for people already limited
by cardiopulmonary impairment, but also for anyone who negotiates rough or unexpected
terrain [77].
Joint Involvement in SSc: is diverse both in distribution that involves large or small
joints and in mechanism with intrinsic musculoskeletal pathology (inflammatory arthritis,
tendonitis, etc) and overt changes (ulceration, calcinosis, inflammation, and fibrosis in
overlying skin and fascial layers). Difficulty managing ADLs makes hand, finger, wrists,
and elbow joints impairment more readily apparent, but the less overt lower extremity joint
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involvement of feet, hips, knees, and ankles interfere with mobility and balance [178–180].
Furthermore, downward cycle of inactivity gradually compounds intra- and peri-articular
adhesion of fibrous tissue that exacerbates joint stiffness and impairment.
Exercise can impede the impairment trajectory [181]. Joint activity instigates blood
circulation that supports tissue health and repair. Myogenic activity decreases local
and systemic inflammation. Motion mitigates tissue adhesion, relieves stiffness, and
malalignment through lubricating and strengthening of periarticular, articular, and bony
structures while promoting repair and regeneration of cartilage [181]. Repetitive exercise
strengthens muscle, ligaments, tendons, and their insertion into the bone [182].

Author Manuscript

Counselling patients on ROM early in the disease course may preserve function, particularly
in dcSSc [183–186]. Warm paraffin hand immersion prior to hand exercise sessions
may significantly improve active ROM, reduce stiffness and hand dryness [187] as well
as increase activity performance and participation [188–190] but these results are not
reproduced consistently [189,190]. Sauna, often available at pool facilities and gyms, is
reported to improve inner core temperature, decrease RP, and facilitate stretching before/
during/after exercise, including aquatic exercise.
Bone Involvement in SSc: results from inflammation, vascular complications e.g.,
calcinosis/osteolysis as well as decreased physical activity, circulation, muscle mass,
and nutrition leading to low bone density, fracture, and avascular necrosis [191–197].
Physical activity invokes muscle contraction and circulatory mechanisms setting off multiple
pathways of benefits for strength and vascularization of the underlying bone as well as
systemic skeletal structure [198–202].

Author Manuscript

Muscle Involvement in SSc: is under-recognized, but commonly found on physical
exam and multifactorial with histological examination ranging from microangiopathy,
inflammation, fibrosis, necrosis, or atrophy [203–205]. Muscle weakness and reduced
muscle endurance are hallmark features of most myositis subsets [206] and reported in
all serological subsets of SSc [207–210].

Author Manuscript

Proximal muscle weakness limits physical function in up to 20% of patients with SSc
[78,205,211]. Muscle endurance is markedly reduced in both shoulder (53% expected)
and hip flexion (40% expected) as measured by Functional Index-2 (FI-2) [212,213],
proximating polymyositis and dermatomyositis impairment [214]. Regardless of subtype
or degree of lung involvement, lower extremity functional muscle strength in SSc is
significantly worse than standard values [212,215], while muscle endurance is lower
in moderate to severe as compared to no or mild lung involvement [83,215]. Muscle
involvement is associated with and possibly predicts cardiac abnormalities [216–224].
Upon exclusion of medication culprits, (e.g., statins, steroids, and hydroxychloroquine)
appropriate, timely management of myopathy includes exercise and rehabilitation to
improve long-term disability and function outcomes [225,226].
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Health-related quality of life in SSc and the role of exercise
HRQoL is the interface of combined symptom distress and impairment with real-life.
Numerous studies demonstrate, independent of traditional disease severity markers, the
inverse correlation of HRQoL and survival and survival improvement with HRQoL-targeted
interventions [4,52,128,227–235]. Whether SSc-specific manifestations or less well-defined
symptoms such as fatigue, pain, psychic/cognitive discomfort, or sexual dysfunction [236],
are the prominent aspects of symptom distress, targeted intervention may markedly improve
HRQoL [103]. The information given below address less SSc-specific, but no less important,
areas of symptom distress.
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Pain in SSc: limits physical capacity in 39% of patients [78]. It is often multifactorial,
diffuse, and unfortunately defaults to an inaccurate diagnosis of “fibromyalgia” [4,237]. RP,
joint, and/or muscle pain, pruritus, skin tightening and subcutaneous pressure, calcinosis,
and ulceration are common causes of SSc pain [4,238]. Though, empiric exercise impedes
mechanisms driving these discomforting manifestations through multiple pathways [4,181],
distinguishing causes of pain and tailoring interventions accordingly may hasten function
[4,181]. Analgesia can improve engagement in those with disabling pre-/post-exercise pain
[181].
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Fatigue in SSc: may be multidimensional with mental/cognitive, motivational, physical,
and muscular domains [239,240]. Although a nonspecific symptom often related to
hypothalamic effects of systemic inflammation, fatigue in SSc often has other factors
that include deconditioning, pain, and inflammation. Serious SSc complications associated
with fatigue such as GI bleeding or undiagnosed PH or ILD or non-SSc comorbidities,
such as clinically significant CVD, must be addressed medically prior to beginning an
exercise program. Malnutrition and poor sleep quality cause fatigue warranting corrective
intervention to optimize health and benefits of exercise [241].
Exercise can increase endurance improving fatigue associated with dyspnea and cough
and ameliorate their psychological burdens of depression and anxiety [63]. Recalcitrant
persistent fatigue, as well as sleep, physical function, and self-perceived general health,
improves with exercise in other conditions [242].
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Anxiety and Depression in SSc: have psychological and emotional consequences for
individuals and their families. SSc requires continued adaptation to changing physiological
burden and symptom severity, e.g., fatigue, pain, respiratory, as well as socioeconomic,
self-image, and survival uncertainties resulting in elements of psychological distress.
Adaptive psychological distress can give way to clinically significant anxiety and depression
alongside impaired cognition and motivation.
“Watchful waiting” may be an acceptable strategy for mild depression [243] whereby
symptoms are anticipated as transient. However, psychological symptoms can interfere with
treatment adherence and key self-management strategies that optimize health and prevent
complications. Non-pharmacological approaches, such as exercise, may require adjuvant
anti-depressant medications even temporarily while patients adjust.
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In SLE, inactivity is associated with tripled incidence of depression [70]. Exercise has
been repeatedly demonstrated to improve cognition, depression, anxiety, self-image, work
performance, and coping. Even a simple change in body positions and postures profoundly
and swiftly shifts mood/affect [102,244–248]. Exercise significantly improves sleep quality
that is foundational to cognitive and psychological health. Evidenced mechanisms through
which exercise affects mental conditioning are numerous and continually growing including
microbiome-gut-brain axis [19,139,249,250] enrichment, facilitating brain’s discarding of
depressive chemicals [251,252] and upregulating antidepressant chemicals [181]. The
impact of yoga, singing [253], and gentle exercise positively impacts both physical and
psychological outcomes [30,35,111–116,254].

Initiation, engagement, and exercise types
Author Manuscript

Documenting exercise/physical activity routinely along with medication history, during
clinic visits provides opportunities for continued encouragement, education, and review of
patient goals and priorities in relation to SSc care (Fig. 4).
Exercise interventions are most effective when guided by patient goals and their life
priorities [90]. Tools such as the Patient-Specific Function Scale PSFS [165,166] support
patients to monitor their own progress. Preventive exercise strategies initiated early in
the disease course, ideally supported by Physical, Occupational, and Respiratory therapist
education on the consistency of practice, stretching safety, and incremental progress, may
preserve physical function and HRQoL [77] by offsetting progressive loss of flexibility and
mobility. Screening for SSc-cardiopulmonary involvement is essential.
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SSc presents additional physical and psychological taxes on motivation [16,255,256] for
exercise. Early on this may include diagnosis-related trauma [15–18], which exercise
may relieve. Both supervised and self-managed exercise initiation strategies require
individualization and flexibility according to levels of fatigue, pain, muscle, skin, joint,
and vital organ involvement. Anticipatory guidance helps patients manage fears, frustrations,
and disappointments, particularly regarding fluctuating fatigue and pain, while sustaining
commitment to exercise. Possible supports include apps/videos or exercise buddies [77]. RP
may deter outdoor exercise in cold temperatures [77] and even indoor exercise that involves
gripping equipment; but is potentially mitigated with exercise glove use.
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Integrating mindfulness techniques and nurturing perceptions of exercise as a friendly,
pleasurable experience, may lessen immobilizing tendencies such as perceived lack of
control, self-consciousness, and defeatism [15–18]. Noticing pleasurable exercise sensations
(e.g., air on skin, massage sensation, etc) may help cultivate parasympathetic (polyvagal)
self-regulation, holistic “core” muscle recruitment, and integration resulting in improved
musculoskeletal performance, balance, joint and postural alignment, and more rapid
escalation of exercise dose (frequency, intensity, time duration, and type (FITT)) [30,257].
Exercise dose begins and escalates gently with a goal of 30 min [49,258] 3–5 days a week.
Fluctuations in disease behavior may require dose adjustment under therapist supervision.
Tables 6, 7a and 7b define exercise approaches, including ROM, muscle strength, muscle
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endurance, aerobic capacity, and functional capacity. Tables 8, 9 summarize, respectively,
cumulative SSc exercise studies and preferential baseline and follow-up assessments [259].
Incremental increases in nonexercise physical activity, e.g., standing, walking, and as much
body movement throughout the day enhances health benefits, physical function, and HRQoL
[48,49]. But while patients with SSc may dedicate time to exercise for health improvement;
nonexercise physical activity throughout the day may be impeded by fatigue, pain, GI
symptoms, or disability prolonging time to complete a routine activity.
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Stretching: is a naturally occurring phenomenon that regulates muscle fiber length and
excess force for optimal muscle tone and protection of periarticular structures (e.g., tendon,
muscle, and ligaments). Stretching is a pivotal conditioning mechanism for ROM, balance,
global and limb proprioception, and movement efficiency [260,261]. Stretching elicits
vasodilatation intensifying blood flow to muscle, increasing oxygenation, warmth and
tissue waste removal, and relieving stiffness. Habitual stretching induces proangiogenic
factors increasing neo-angiogenesis and capillary density [262], potentially impacting
multiple SSc therapeutic avenues. Effective stretching occurs when muscle fiber exceeds
its optimal length and/or the magnitude of stretch is guided by ROM and pain limitations
Implementation is gentle, and held for 30–60 seconds synchronized with breath cycles for
sufficient relaxation [50]. Long-term benefits of therapeutic hand stretching with marked
improvement in hand, arm, and overall function in SSc [156] warrant further investigation in
diverse SSc manifestations.
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Water-based: Water’s properties of buoyancy, depth-graded hydrostatic pressure, viscosity,
surface tension, hydromechanics, thermodynamics, and density [263–270] allow for
uniquely efficient rehabilitation strategies (Table 11). Growing high-level evidence
of aquatic exercise in autoimmune and other conditions demonstrates safety without
neuromusculoskeletal exacerbations or other adverse effects. Additionally, demonstrated
are efficacy in diminishing stiffness, pain, muscle spasm, fatigue, and improving
cardiovascular endurance as well as physical function, including ROM, balance, and
walking [183,263,264,266–269,271–278]. Despite strong rationale only one study [183] as
yetinvestigated aquatic exercise in SSc, which demonstrated significantly improved HRQoL,
physical function, and activity [183].
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Though a more easy exercise medium [266], water deceptively requires greater muscle
activity and provides an optimal environment for wide-ranging therapeutic interventions,
including strength-training, cardiopulmonary rehabilitation, and for circulatory disorders
[272,279]. Joint mobilization and stretching, balance, gait, resistance, strength [269] and
endurance training, and weight-bearing activities are more easily modified in water to
accommodate a spectrum of abilities. Patients explore movement strategies and patterns
against gravity without anxiety or fear of falling.
Water temperatures between 30 °C and 34 °C/86 °F –93 °F preserves optimal body heat,
exercise tolerability, and HRQoL effects [273–277]; cooler/cold water can induce RP and
increase joint and muscle stiffness. Water bidirectionally conducts heat 25 times faster than
air facilitating deeper, more rapid tissue penetration [263,264], but also more rapid body
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heat dissipation, thus enabling increased exercise duration and intensity with less fatigue
[267,270]. These sublime factors can unwittingly lead to overexertion. Patient logistical
concerns regarding oxygenation, fatigue, and mobility challenges with dressing, drying, and
skincare are important considerations [280].

G-FoRSS preliminary research agenda

Author Manuscript

Despite significant evidence of exercise effects on inflammation and circulatory flow
and repair, further work is needed to define exercise as a medicinal disease-modifying
intervention with patient-centered strategies that support sustained patient engagement. We
provide a roadmap to examining exercise in SSc (Table 11) with the hopes of building
collaboration and to stimulate interest in the wider research community in the disease
modifying and HRQoL-preserving effects of exercise in SSc. These include examining, and
ultimately, prescribing FITT in terms of quantifying exercise intensity, duration, and type to
target circulatory, anti-inflammatory, and respiratory effects; along with how these effects
translate to meaningful changes for patients in terms of physical and psychological function
and HRQoL. The potential impact of both general and targeted exercise on skin tightening,
RP, wound healing, and mobility is compelling for both the prevention and treatment of SSc
complications.
With few therapeutics demonstrating improvement of SSc manifestations, exercise and
physical activity demonstrate convincing mechanisms of action, with virtually no downside.
Instead exercise consistently promises major and diverse benefits, and deserves robust
research attention. Furthermore, engaging in exercise allows patients to foster some control
and self-efficacy in managing a frightening disease.
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G-FoRSS is committed to supporting research efforts in addition to the
following:
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•

Patient experiences of exercises prior to and concurrent with SSc diagnosis:

•

Patient perceived and quantitative impact of exercise on SSc manifestation,
symptom, and HRQoL domains

•

Patient perceptions, fears, hopes, and worries related to engaging in exercise

•

Patient perceived barriers/hindrances to initiating and to sustaining exercise
practice

•

Patient perception and quantified impact of early ROM intervention on face,
mouth, hands, shoulders, and feet

•

Characterizing optimal FITT in both aerobic and resistance exercise on land and
in water, in patients without/with cardiopulmonary involvement

•

The use of minimally invasive / sutureless muscle biopsies to evaluate response
to exercise

•

A focus on optimal hand exercise regimens and implementations
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•

A focus on the impact of facial exercises on oral health, salivation, and nutrition

•

A focus on the impact of exercise, including singing and diaphragmatic strength
on GI symptoms and GI-related quality of life

•

Examining the impact of exercise interventions from a health economics
perspective

•

Establishing clear safety parameters for exercise in relation to the presence and
extent of cardiopulmonary involvement

•

Examining treatment effects of exercise on SSc-myopathy

•

Assessing patient-preferred education and engagement modes for initiation and
sustained exercise

Author Manuscript

Summary
Exercise possesses essential health benefits for everyone and perfectly addresses the World
Health Organization’s preamble to their constitution to ‘address health as a state of complete
physical, mental and social well-being and not merely the absence of disease or infirmity’
[281]. The therapeutic underpinnings of exercise target the specific mechanisms behind the
pervasive SSc-disease biophysical and psychosocial manifestations. Exercise engagement
should be a routine treatment-based discussion with respect to patients’ goals and clinical
assessment.
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The expanse of exercise as a treatment intervention in SSc warrants dedicated investigation
with standardized approaches. This group has convened to prioritize a research agenda
for exercise in SSc and accelerate selected research through the development of a global
network of interdisciplinary SSc specialists and patient research partners.
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APPENDIX
SUPPLEMENTAL FILES and RESOURCES:
Patient and Physician Education and Advocacy Organizations:
Scleroderma Foundation: www.scleroderma.org.
Federation of European Scleroderma Associations (FESCA): www.fesca-scleroderma.eu/
wordpress/
Scleroderma Australia: https://www.sclerodermaaustralia.com.au/
Scleroderma & Raynaud’s UK (SRUK): https://www.sruk.co.uk/scleroderma/

Author Manuscript

Swedish National Association of Systemic sclerosis: https://rss.reumatiker.se/
Instructional Resources:
Janet Poole Hands/Face Instructional Links: https://www.youtube.com/watch?
v=1F02FxdOgwI
https://www.youtube.com/watch?v=8MztM3zItik
https://www.youtube.com/watch?v=YwWP7mgcYhU.
Stretching exercises for the hand and face.
The Scleroderma Foundation, http://www.scleroderma.org/site/DocServer/
Form_16c_low_res.pdf?docID=19809&AddInterest=1281.

Author Manuscript

Taking Charge of Systemic Sclerosis (TOSS): an internet program for systemic sclerosis.
https://www.selfmanagescleroderma.com/
Living Well: Heart, Lung, Muscle & Mind: A collection of videos dedicated to yoga rehab
and dance rehab for heart, lung, muscle, and autoimmune conditions
https://www.youtube.com/channel/UCRgvkbyzep-Q3LGBiAksQZw/videos.
3–3-1 Exercise Tutorial https://www.youtube.com/watch?v=zsBRxmkzAnM&t=2s.
Move Towards Health: UMC CPHC Instructional Booklet on Safe Home-based Dance
Practice https://doi.org/10.13140/RG.2.2.25576.49927.
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Sleep Booklet: https://www.dropbox.com/s/0axd782mi818smc/
SF%20Arizona%20Conference%20-%20SLEEP%20-%20DOUBLE%20Booklet.docx?
dl=0.
Mindfulness
Booklet: https://www.dropbox.com/s/mrpl33zxjsk20br/SF%20Arizona%20Conference%20
%20RESTORE%20YOURSELF-%20DOUBLE%20Booklet.docx?dl=0.
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Mindfulness in Scleroderma Videos: https://www.youtube.com/watch?v=pNK9RP4Abyw.
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https://www.youtube.com/watch?v=lmQKOCDJ19Y
Clinical Resources:
Patient Specific Functional Scale (PSFS) User Manual: https://www.physio-pedia.com/
Patient_Specific_Functional_Scale.
Functional Index-2: https://www.youtube.com/watch?v=qw4XvWKQErU.
Manual Muscle Test 8 (MMT8): https://www.niehs.nih.gov/research/resources/assets/docs/
mmt8_grading_and_testing_procedures_for_the_abbreviated_8_muscle_groups_508.pdf.
Timed Up and Go Test: https://youtu.be/auqAb_AWM1U.
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TImed sit to stand test: https://www.youtube.com/watch?v=puJhQXUlbdA.
30-s Sit to Stand Test: https://www.youtube.com/watch?v=PzCTwkJVhWg.
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Practice points

Author Manuscript

•

Progress in exercise and physical activity should be documented on the
history of present illness, with physical activity goals clearly stated

•

Discussions and counselling on physical activity and exercise are an essential
component of SSc care and overall health

•

Highlighting the impact of exercise on improved circulation and decreased
inflammation may support patient engagement in exercise

•

Explaining the benefits of exercise according to patients’ individual SSc
symptoms may support patient engagement

•

Initiating face, mouth, hand, and possibly shoulder ROM exercises early may
prevent disability and impact skin tightness as well as local circulation and
inflammation

•

The need for referral to OT/PT/RT should be considered at each patient visit

•

Reminding patients at each visit of available online Scleroderma instructional
resources e.g., The Scleroderma Foundation
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Fig. 1.

All movement is healthful. This diagram perspects the relation of exercise in the larger arena
of physical activity with the description of activity intensity by estimated heart rate and lay
description (Courtesy of LA Saketkoo on behalf of G-FoRSS, rights reserved).
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Fig. 2.

Muscle Contraction-Induced Myogenic Mechanisms Facilitating Health. FSTL-1:
Follistatin-like 1 IL: interleukin, MCP: monocyte chemoattractant protein-1, TLR-7: Toll
Like Receptor-7, and TNF: Tumour Necrosis Factor (Courtesy of LA Saketkoo on behalf of
G-FoRSS, rights reserved).
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Fig. 3.

Overview of Potential Exercise Benefit relational to anatomical manifestations of SSc in
Male and Female subjects. Abbreviations: DU: Digital Ulcer, ECM: Extracellular Matrix,
GERD: gastroesophageal reflux; GI: Gastrointestinal, HRQoL: Health-Related Quality of
Life, ROM: Range of Motion, RP: Raynaud Phenomenon, and TMJ: Temporal-Mandibular
Joint (Courtesy of LA Saketkoo on behalf of G-FoRSS, rights reserved).

Author Manuscript
Author Manuscript
Best Pract Res Clin Rheumatol. Author manuscript; available in PMC 2022 September 01.

Pettersson et al.

Page 39

Author Manuscript
Author Manuscript
Fig. 4.

G-FoRSS preliminary recommendations for physical activity and exercise in SSc. Based
on evidence collated from the WHO, SSc disease mechanisms and health promoting
mechanisms of exercise (Courtesy of LA Saketkoo on behalf of G-FoRSS, rights reserved).
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Summary of definitions and recommendations for physical activity, related to health benefits and exercise
[45,48–50,282] (Courtesy of LA Saketkoo on behalf of G-FoRSS, rights reserved).
Physical
Activity (PA)
Definition of
Physical Activity

Any everyday activity producing increased energy expenditure above resting (sitting) levels. The antithesis of sedentary/
nonmotion moments
An unrestricted spectrum of activity, including exercise, household and employment tasks, mobility, leisure activity such as
sports, hobbies, and singing
Occurs in varying intensities: light/low, moderate, high, and vigorous
Any PA is healthy and contributes to fitness; general health is more favorably impacted with increasing time and intensity
of relevant PA

Author Manuscript

Recommended
Weekly Dosage
of Physical
Activity

150 min of moderate-intensity PA weekly for ≥10 min at a time
OR
75 min of vigorous-intensity PA weekly for ≥10 min at a time
OR
an equivalent combination of moderate- and vigorous-intensity PA for ≥10 min at a time
PLUS
-Strengthening exercise involving major muscle groups (legs, back, chest, abdomen, shoulders, and arms) ≥2 days weekly
* Additional health benefits can be attained by doubling the minutes per week above

Physical Activity
for Special
Populations

For Adults ≥ 65 Years Old

People with Chronic Illness

Same recommendations as above.
OR

Author Manuscript

If limited by health condition, engagement in PA as abilities and conditions allow
PLUS
Limit amount of sedentary time, replacing it with PA of any intensity (including light intensity)
PLUS
If mobility is impaired, PA to enhance balance and prevent falls for ≥3 days weekly
Intensity of
Physical Activity

Light/Low

Moderate

High

Vigorous

Similar intensity as rest
Minimal effort
Able to chat easily

50%–70% of max HR
3–6x effort as rest
A bit difficult to converse

>70% of max HR
6–10x effort as rest
Difficult to converse

>85% max HR
>10x effort as rest
Unable to converse

Even light intensity PA can support cardiovascular health and can help with weight loss
An activity’s intensity is dependent on an individual’s baseline fitness level
An activity’s intensity decreases with an individual’s increasing fitness

Author Manuscript

Definition of
Exercise (a
subset of PA)

A subset of PA that is repeated over time with specified intensity, duration, and frequency
Directed targets improvement of any aspect of physical fitness: cardiorespiratory, mobility, muscle strength, general health,
wound healing, psychological, cognitive, etc.
Recommendations for exercise to improve aerobic fitness is 30 min/day for ≥3–5 days weekly at ≥ moderate intensity, at
least a bit difficult to converse
Recommendations for exercise to improve muscle strength (weights allowing a maximum of 8–12 repetitions) or muscle
endurance (weights allowing a maximum of 15–25 repetitions) is 2–3 days weekly with a rest period of 48–72 h
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Summary of the American College of Sports Medicine exercise recommendations for general population and
in rheumatic and musculoskeletal diseases [50,282] (Courtesy of LA Saketkoo on behalf of G-FoRSS, rights
reserved).
Exercise type

Exercise Goal

Intensity

Duration

Frequency

Aerobic
exercises

Improve aerobic capacity, i.e.,
cardiopulmonary fitness

55%–90% of HRmax

20–90 min

3–5 days/week

Resistance
exercises

Improve muscle strength

60%–85% of 1 RM

8–12 repetitions, 2–4 sets.
Exercises should induce fatigue
but not exhaustion

2–3 days/week

Improve muscle endurance

30%–50% of 1RM

15–25 repetitions with variable
number of sets

2–3 days/week

Improve range of motion and
flexibility

Most effective when muscles/
tissue is warm, e.g., after
exercise and/or external heating
(sauna, heat packs, or paraffin
bath)

Approximately 10 min

≥2–3 days/week

Stretching
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Abbreviations: HRmax: maximum heart rate and RM: repetition maximum.
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Overall benefits of exercise in general populations (Courtesy ofLA Saketkoo on behalfofG-FoRSS, rights
reserved).
SYSTEMIC

Brain Health
Cardiovascular health
Cardiopulmonary health
Circulatory function and repair
Immune Function
Decreased inflammation
Malignancy prevention
Bone density
Bone circulation
Increased muscle mass

Author Manuscript

Skin health
Gastrointestinal health
Endocrine health
Exocrine health including sweat and salivation
Malignancy prevention
GLOBAL FUNCTION

Activity capacity
Physical conditioning and strength
Health-related Quality of Life
Alertness
Cognition/Reduced Risk of Cognitive Decline
Mobility (walking, climbing, running, and cycling)
Balance

Author Manuscript

Improved self-care
Workability
Social Function
Sexual health
CONSTITUTIONAL

Decreased anxiety
Decreased depression
Decreased pain
Decreased fatigue
Improved sleep

LOCAL

Lung mechanics
Chest kinematics
Muscle pathology

Author Manuscript

Range of motion
Articular strength
Articular and Periarticular Lubrication
Muscle strength
Muscle mass
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Decreased inflammation
Decreased stiffness
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SSc disease mechanisms and drivers targeted by exercise.
Circulation
Heat generation
Nutrient delivery
Aerobic exchange
Toxin clearance
Vascular repair
Vascular responsiveness
Systemic Inflammation
Downregulation of inflammatory cytokines
Downregulation of inflammatory cell recruitment
Resultant decreased triggering of fibrotic pathways
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Fibrosis
Degradation of fibrosis
Possible halting or reversing of fibrosis in evolution
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Potential impact of exercise on SSc disease manifestations (Courtesy of LA Saketkoo on behalf of G-FoRSS,
rights reserved).
SSc Manifestation

Potential Impact of Exercise

Inflammation

Downregulated with exercise

Immunosuppression/Immune dysfunction

Probable improved immune function

Fatigue

Reduction of multidimensional fatigue

Sleep

Improved sleep after exercise
Sleep quality correlates to inflammation fatigue and HRQoL

Psychological Impact

Improved confidence
Increased self-esteem Improved mood
Self-perceptions of healthy/“not sick”
Reduced stress, anxiety, and worries

Author Manuscript

Reduced depression
Improved HRQoL
Cold sensation/cold injury

Increased heat to core body
Increased distal extremities

Ischemia/RP

Increased oxygenation/gas exchange to extremities
Improved wound healing
Possibly reduced DUs, calcinosis, and osteolysis
Possibly improved sexual function

Gastrointestinal Dysmotility

Reduced nausea
Reduced bloating
Enhanced peristalsis/digestion and reduced constipation

Author Manuscript

Diarrhea

Improved microbiome profile

Arthropathy

Joint lubrication
Decreased stiffness
Decreased inflammation
Increased mobility, flexibility, and dexterity
Strengthening of periarticular muscle support

Skin tightness

Possible reduced skin tightening
Possible degree of preservation of skin function e.g., sweating
Possible reduction of subcutaneous edema

Myopathy

Improved muscle strength

Myositis

Improved muscle endurance

Atrophic myopathy

Improved aerobic capacity and vascularization of muscle
Reduced muscle inflammation

Author Manuscript

Enhanced muscle recovery
Increased muscle mass, with correlates to decreased inflammation
Oral aperture

Improved mouth opening
Oral health improvement

Facial changes

Improve mouth function
Possibly improved facial expression and verbal communication
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SSc Manifestation

Potential Impact of Exercise

Pain

Pain reduction
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Decreased stiffness
Respiratory capacity and breath phrasing

Improved tolerance to dyspnea
Improved exercise tolerance

Need for pharmaceutical treatment

Less need of pharmaceuticals to improve blood circulation
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Eligibility and safety of exercise in SSc (Courtesy of LA Saketkoo on behalf of G-FoRSS, rights reserved).
Who can Exercise:
SSc patients without
pulmonary involvement

Concluded to partake without restriction [120]

SSc patient
with cardiopulmonary
involvement

Considered feasible, safe, and effective [118,283]regardless of underlying diagnosis (e.g., ILD and PH) [120]

SSc patients with mild
pulmonary involvement

Safely able to engage in moderate aerobic intensity with moderate-load resistance exercises [120]

SSc patients
with myopathy
and cardiopulmonary
involvement

May warrant special attention focusing on strengthening

Pre-Exercise Screening for:
ILD

- Symptomatology

Author Manuscript

- Serial FVC
- Serial DLCO
- 6MWT for desaturation
+/− HRCT of Chest
PH

- Symptomatology
- Annual echocardiogram at rest and with exercise
- Serial DLCO
- 6MWT for desaturation
- Right heart catheterization (gold standard) if symptomatology or testing is concerning

Further screening

Cardiac magnetic resonance imaging (CMR) is the gold standard to assess:
- right and left ventricular systolic function (LVSF)
- myocardial fibrosis

Author Manuscript

- pericardial disease [284]
Safety Parameters

- Regular monitoring of blood pressure, heart rate and preferably, forehead oximetry [123] with formal exercise
programs.
- Severe symptoms and exercise-induced desaturation require individualized modification of intensity and duration
[285]
- Supplemental oxygen [118,285] is required for abnormal desaturation Forehead oximetry [123] over digital
oximetry SpO2 may reduce Raynaud-related falsely low readings
- Borg CR-10-scale to assess dyspnea and leg tiredness [286] as well as the Borg RPE-scale, Rating of Perceived
Exertion can inform baseline and follow-up assessments [287]
- The treating physician should always be notified of any unexpected abnormal assessments, e.g., heart rate, oxygen
saturation, etc. or large drops in saturation

Programmatic
Considerations

Regardless of SSc manifestations, load intensity, and repetitions are adjusted according to symptoms and tolerance
(ref 7).

Author Manuscript

Diverse effective modalities such as continuous versus interval aerobic training can be intensified up to 75%–80%
of the patienťs projected maximal load based on their physical condition and comorbidities while monitoring
intensity parameters e.g., breathlessness severity, leg fatigue, and heart rate.
Combined aerobic, resistance, and respiratory muscle training induces the strongest improvement in functional
capacity reflected by 6MWD and VO2 peak [104]
In severe cardiopulmonary disease, unilateral resistance training may be more accessible over dynamic resistance
training.
In exercise-related induced sPAP elevation, interval training is the preferred safer approach due to load reduction on
the vessels of the systemic and pulmonary circulation.
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Who can Exercise:
In ILD, initiating endurance training between 70% and 80% of max exercise capacity.

Author Manuscript

Interval training may be an alternative in ILD with periods of relative high-intensity training interspersed with
periods of rest/low-intensity training allowing for time to recuperate and lessen breathlessness and fatigue [285]
In PH, it is advisable to avoid interval training due to the associated risk ofrapid changes in pulmonary
hemodynamics and risk of syncope [288–290] However, new research and guidelines may bring clarity to optimal
exercise strategies in both ILD, PH and the combination of ILD and PH.

Author Manuscript
Author Manuscript
Author Manuscript
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Table 7a

Author Manuscript

Stratifies patients with SSc for engagement in exercise (Courtesy of LA Saketkoo on behalf of G-FoRSS,
rights reserved).
Strata of Engagement

Advisement

Comments

No pulmonary involvement

Unrestricted but targeted to patient needs and
tolerance

Gradual increment of intensity, repetitions, and
duration

Mild cardiopulmonary symptoms

Moderate aerobic intensity with moderate-load
resistance exercises

Gradual increment of intensity, repetitions, and
duration

Severe cardiopulmonary symptoms

Individualized modification of intensity and duration,
with supplemental oxygen as needed [118,290]

Can be intensified up to 75%–80% of patient’s
projected maximal load

Desaturation with exercise

As above for severe cardiopulmonary symptoms

Increase of systolic pulmonary
artery pressure with exercise

Load reduction on systemic and pulmonary
circulation is an important consideration

Rapid changes in pulmonary hemodynamics
Interval training may increase the risk of
syncope [290]

Author Manuscript
Author Manuscript
Author Manuscript
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Table 7b

Author Manuscript

General considerations for exercise in SSc* (Courtesy of LA Saketkoo on behalf of G-FoRSS, rights reserved).
Concept

Advisement

Exercise Initiation

All patients screened for clinically significant ILD and PH
Assess current activity levels with FITT
Consider assessing patient goals with PSFS

Sustaining exercise

Comments

Aerobic and muscle testing prior to start of exercise

Submaximal ergometer cycle test or treadmill test
and muscle tests like TST, 30-sec CST, and FI-2

Anticipatory guidance of fluctuating fatigue/pain challenging
exercise.

Encourage mindfulness practice and pleasure
principals during exercise to redirect frustration and
disappointments.

Education on stretching safety

Emphasis on consistency of practice and expectations
of incremental improvement.

Developing alternate options for inclement weather or GI
exacerbations

Adaptations
Indoor options
Online class options

Author Manuscript

Consider monitoring achievement with PSFS
Start gently and escalate with improvement
Recommendation for home general physical activity (e.g.,
walks) 30 min/5 days weekly

Myopathy

Aerobic and muscle testing after exercise period to evaluate
intervention

Submaximal ergometer cycle test or treadmill test
and muscle tests like TST, 30-sec CST, and FI-2

Screen for myopathy

In tandem with rheumatologistyet, determine if
targeted strengthening required

Assess degree of myopathy preferably using FI-2 or FI-3
Nutritional status

Assess for low nutritional status

Consider adjustment of calorie intake to exercise
related consumption

Face, Mouth, Hand,
Wrist, and Shoulder
ROM exercises

Ideally encouraged to be daily or twice daily “ritual”

Frequency may be increased at induction and
decreased for maintenance.

Author Manuscript

Patients can also implement throughout the day as
needed for relief.
Raynaud

Indoor temperature
Outdoor temperature
Gripping equipment
Erroneous oximetry results

Digital ulcers

Require bandaging and protective gloves prior to handling
equipment
Require bandaging and gloving with paraffin wax emersion

Warming

Hands for improved exercise performance

Consider paraffin bath immersion

Sauna

To improve core warmth prior exercise, both in water
and on land

Feet

Alternate plans for inclement weather Use of exercise
gloves
Forehead oximetry to avoid falsely low readings

Screen for foot pain
Assess degree and cause of foot pain

Cardiopulmonary

Advise on proper footwear with insoles or referral to
podiatry where necessary

Author Manuscript

Screen for extent and severity Interval monitoring pulse, blood
pressure and forehead oximetry Adjust exercise for symptom
severity Use supplemental oxygen to keep levels appropriate
for exercise [285,291] in ILD [290] and PH [285,290]
Combined aerobic, resistance, and respiratory muscle training
induces the strongest improvement in functional capacity
Dynamic resistance training in severe cardiopulmonary disease
may require a switch to isolated, unilateral resistance training

Stretching

Stretching ideally is done regularly to condition anatomic
proprioception, balance, and muscular responsiveness.

Stretching is also performed before and after other
forms of exercise to increase circulation into the
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Advisement

Comments

Stretching is essential to maintain ROM and protect the muscle
from excessive force

muscle, warm muscle, and prepare the muscle to
be responsive enough to protect itself and articular
structures by the regulation of force and stretch

Each flexibility exercise is held for a total of 30–60 s (e.g.,
45 s once or 15 s thrice), preferably synchronized with breath
cycles, to allow for muscle fibers to relax into its optimal
length

Bouncing or pulsing a stretch is considered unsafe.
Stretching the point of a “resistance sensation” or
“pleasurable pain” but not a “bad pain” to avoid
damage ≥30 s may be more beneficial

Warming the area of the body prior to stretching with loose
fluid movements, sauna, or warm wax

Moving the general body area for about a minute
with arm circles shaking, marching, etc., warms and
relaxes muscle before stretching.

Rinse off chlorinated or salted water Moisturize skin post
exercise
Exhaustion may occur with changing of clothes and being wet
at room air for extended length of time

Provide attendant support

Water temperature between 30 °C −34 °C and 86 °F −93 °F

Water is a rapid conductor of heat. Lower
temperature water draws heat from the body

Advisement on pacing with gradual increase of duration and
intensity

To protect against unintended overexertion

Author Manuscript

Abbreviations: FITT: frequency, intensity, time duration and type; FI-2: functional index 2; FI-3: functional index 3; ILD: interstitial lung disease;
PH: pulmonary hypertension; PSFS: Patient-Specific Function Scale; TST: Timed-stands test; and 30-s CST: 30-s chair stands test.
*

Treating physician must be apprised of any new oxygen requirement or new cardiopulmonary symptomatology e.g., arrhythmia, syncope/pre
syncope, etc.

Author Manuscript
Author Manuscript
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Table 8

Author Manuscript

Comprehensive profile of published exercise studies in SSc to date.

Author Manuscript
Author Manuscript
Author Manuscript

Interventions and Exercise
Type

Primary outcomes

Secondary
outcomes

Adverse
events

Oliveira et al.
(2009) [292]

7 SSc(2 dcSSc and 5
lcSS) and 7 healthy
controls.
No pulmonary
involvement on CT
or PASP ≤40 mmHG
or FVC and DLCO
<75% of predicted.
2 dropouts in SSc.

Aerobic exercise
2x/wk for 8 wks of 40 min on
treadmill.

VO2peak
improved
significantly in both
groups.

Improved peak
exercise oxygen
saturation in
SSc after it
was compared to
baseline.

No
adverse
effects
reported.

Pinto et al.
(2011) [121]

11 SSc (8 dcSSc and 3
lcSSc).
No evidence
of moderate or
severe pulmonary
involvement or PASP
≤40 mmHG or FVC
and DLCO <75% of
predicted.

Aerobic exercise
2x/wk for 12 wks of 20 min
on treadmill.
Resistance training for 30
min for 5 main muscle groups
in 8–12 reps x 4 sets.

VO2peak Improved.

Significant
improvements in
muscle strength.

No
adverse
effects
reported.

6MWT, no significant
change.

Muscle function:
(Functional Index
2, shoulder
flexion and hip
flexion) improved
significantly in 3
patients.
No significant
changes, but trend
of reduced fatigue
in 3 patients.

No
exerciserelated
adverse
events.

VO2peak improved
significantly in ACE and
CE after intervention.

Life-satisfaction
improved in both
ACE and CE.
Discomfort and
Raynaud’s pain
decreased in both
ACE and CE as
well as improved
life satisfaction.

No
exerciserelated
adverse
events.

VO2peak improved
statistically in ACE
compared with CG.

Improved
endothelia
dependent reactivity
in ACE as
well as improved
transcutaneous
oxygen pressure
in finger.

No
adverse
events
reported.

6 MWD improved
statistically in IG
compared with CG.

Improved q-ceps,
biceps, and grip
strength as well as
improved physical
score in SF-36 in
IG when compared
with CG.

3 patients
in IG
droppedout due to
pain in
joints and
other
parts.

Publication

Population/Dropouts

Aerobic and Muscle Performance

Alexanderson et
al. (2014) [293]

Mitropoulos et
al. (2018) [100]

Mitropoulos et
al. (2019) [294]

Filippetti et al.
(2019) [103]

SSc, n = 4.
2 with lung fibrosis
with FVC 50% resp
80% while the other 2
had FVC 100%.

Aerobic exercise
on ergometer cycling of 30
min.
Muscular endurance
exercise of shoulder and hip
flexors for 30–50 min 3x/wk
for 8 wks.

LcSSc, n=34.
No lung involvement
nor myositis or
NYHA class 3–4.
Dropouts: 1 patient in
each group.

Aerobic exercise
with ACE, n = 10 or CE n =
10.
ACE = 2 days/wk for 12
wks of 30 min sessions of30
s HIIT followed with 30 s
passive recovery.
CE = 2 days/wk for 12 w
of 30 min with bouts of 30
s HIIT followed with 30 s
passive recovery. CG, n = 11,
and no exercise.

LcSSc, n = 32.
No PAH or ILD or
myositis or NYHA
class 3 or 4.

Aerobic Exercise (n = 16),
ACE = 2 days/w for 12 wks
of 30 min sessions of 30 sec
HIIT followed with 30 sec
passive recovery.
Resistance training, 5 upper
body exercises in 10 reps x 3
sets.
CG, n = 16, and no exercise.

SSc, n = 44, and 22
each in both IG and
CG
No PH, VC ≤50%,
and DLCO ≤30% or
NYHA class 3 or 4.
Dropouts in IG n = 6
and CG n = 5.

A 6 months, 3 days/wk,
minimally supervised home
rehabilitation program in IG,
no exercise in CG.
Aerobic Exercise, CG,
stationary bike at 60%
intensity for 15 min, 3 min
rest, and 15 min bike.
Muscular endurance
exercise for upper limbs with
load of 60% of 1RM.
Stretching for hands.
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Author Manuscript
Author Manuscript
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Interventions and Exercise
Type

Primary outcomes

Secondary
outcomes

Adverse
events

10 SSc with oral
aperture <30 mm.

Mouth stretching and oral
augmentation exercises for 15
min twice a day for 18 wks.

Mouth opening
significantly increased;
subjective improvements
in eating, speaking, and
ability to perform oral
hygiene.

N/A.

Mild
muscle
fatigue in
cheeks.

17/21 SSc (9
dcSSc and 8 lcSSc)
completed all visits.

Mouth exercises and oral
augmentation exercises in
combination with education
on brushing and flossing
teeth and adapted dental
appliances.

Dental hygiene improved
significantly for
decreased bleeding,
supragingival calculus,
and increases in
caries. No significant
improvement in mouth
opening.

N/A.

None
reported.

IG: 26(13 dcSSc and
13 lcSSc).
CG: 22 (8 dcSSc and
14 lcSSc).

IG: powered toothbrush and
flosser plus mouth stretching
and oral augmentation
exercises held for 15–20 s, 3
times each, 2 times/day for 6
months if oral aperture <40
mm CG: manual toothbrush
and dental floss 2 times/ day
for 6 months.

Oral aperture significantly
increased as compared to
controls at 3 mo but not at
6 mo. Gingival
inflammation was
significantly reduced in
both groups. IG showed
a significantly larger
reduction in inflammation
than CG.

N/A.

None
reported.

Stretching exercises for joints
of the hand. Position held 10 s
with 3–10 repetitions.

TPM improved at 1
month
postintervention, which
improved or was
maintained at 1 yr. No
change in HAQ but
individual item score
improved.

N/A.

None
reported.

No group differences.
Both groups showed
improvements in hand
function; HAQ and
HAMIS for the R hand
improved significantly
only in IG.

No group
differences. Pinch
strength and MCP
ROM for R hand
increased
significantly in both
groups; no increases
in pain, global
health, or SF-36.

None
reported.

IG had significant
improvements with
perceived satisfaction and
performance of daily
tasks (COPM), HAQ and
SF-36 mental health at
3 months. Significant
differences between IG
and CG at 3 months was

N/A.

None
reported.

Population/Dropouts

Oro-Facial Exercises

Pizzo et al.
(2003) [295]

Poole et al.
(2010) [296]

Yuen et al.
(2011, 2012)
[297,298]

Hand Exercises

Mugii et al.
(2006; 2019)
[299,300]

45 SSc (32 dcSSc and
13 lcSSc).
2 dropouts from yr 1
to yr 9.

At 3-yr follow-up,
TPM improved and was
maintained or improved
at 9 yrs after the first
visit. No change in HAQ
at 9 yrs except in patients
who also had decreased
TPM related to worse
skin scores.

Piga et al.
(2014) [301]

IG: 10 SSc (2 dcSSc
and 8 lcSSc).
CG: 10 SSc (2 dcSSc
and 8 lcSSc).
No irreversible
anatomical damage,
active arthritis, or
digital ulcers.
2 dropouts in CG.

IG: 5 mobility and 3
strengthening exercises for
the hand to be done at home
5 d/wk for 12 wks monitored
remotely for number of
repetitions, force, speed, and
correctness.
CG: Home program of 3
mobility and 3 strengthening
hand exercises to be done 5
d/wk for 12 wks.

Author Manuscript

Stefanantoni et
al. (2016) [158]

15 IG (7 dcSSc and 8
lcSSc).
16 CG (5 dcSSc and
10 lcSSc).
No active synovitis,
DU.

Hand exercises tailored to
participants’ goals; met at 1
mo and 3 mo with weekly
phone calls between sessions.
CG: general instruction to do
exercises 1x/day.
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Population/Dropouts

Interventions and Exercise
Type

Primary outcomes

Author Manuscript

Secondary
outcomes

Adverse
events

SHAQ and SF-36
improved in IG but
not in CG.

None.

perceived performance on
daily tasks.

Landim et al.
(2017; 2020)
[184,186]

IG: 40 (22 lcSSc and
18 dcSSc).
CG: 17 (11 lcSSc and
6 dcSSc).
No previous hand
rehab, hand disease
not due to SSc, or
unable to perform
exercises.

IG: Home hand exercise
program consisting of booklet
and video disc; revaluated at
4,8, and 24 wks. CG: usual
care; revaluated at 24 wks.

VAS-pain, CHFS, ΔFTP,
grip, and tip and
pinch strength increased
significantly in IG but not
in the CG.

Author Manuscript

ACE, arm crank ergometer; CE, cycle ergometer; CG, control group; CHFT, Cochin Hand Function Test; COPM, Canadian Occupational
Performance Measure; CT, computerized tomography; dcSSc, diffuse cutaneous SSc; DLCO, diffusing capacity for carbon monoxide; DU,
digital ulcers; ΔFTP change finger to palm; FVC: forced vital capacity; HAMIS, hand mobility in scleroderma; HAQ, health assessment
questionnaire; HIIT; high-intensity interval training; IG, intervention group; ILD: interstitial lung disease; lcSSc, limited cutaneous SSc; MCP
ROM: metacarpophalangeal range of motion; N/A, not applicable; NYHA: New York heart association (class 1e4); 1RM, one repetition maximum;
PAH: pulmonary arterial hypertension; PASP: pulmonary artery systolic pressure; PH: pulmonary hypertension; R hand, right hand; SF-36:
Medical Outcomes Survey Short Form; SHAQ, Scleroderma HAQ; 6MWT: Six-minute walk test; TPM, total passive range of motion; VAS: visual
analogue scale; VC: vital capacity; q-ceps: quadriceps muscle; and VO2peak: peak oxygen uptake.

Author Manuscript
Author Manuscript
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Table 9

Author Manuscript

Clinically feasible assessments in patients with SSc.
Quality to
Assess

Test

Description

Range of
motion

Functional Shoulder Assessment
(FSA) [302]

Assessment of 6 functional movements of the upper
extremity.

Muscle
endurance

Functional Index 2 (FI-2) [213]

Dynamic assessment of quantity of repetitions before
exertion in 7 muscle groups.

2FI-2 is feasible, good
to excellent inter- and
intrarater reliability in
SSc (unpublished data,
Pettersson).

FI-3 [303] revised shorter version
of FI-2, feasible for clinic visit
physical exam

As above, examining 1 to 3 muscle groups.

Especially hip, shoulder, or
neck flexion.

Timed-Stands Test TST [78,215],

Time required to rise from chair 10 times.

Only valid if patient can do
all 10 reps.

30-s Chair-Stands Test CST [304],

Number of full rises from chair during 30 s.

Particularly for patients
unable to complete TST.

Treadmill, Ebbelings test [51]

Submaximal aerobic test, walks for 4 min at a
selfselected pace followed by 4 min, at the same pace,
but with a 5% elevation.

More suitable for
older/ more lung-impaired
patients.

Cycle ergometer test, Astrand test
[305]

Submaximal aerobic test, 6 min ergometer biking.

Functional
capacity

6MWT, 6-min walk test [306]

Walking distance on flat ground for 6 min.

Hand grip
force

Grippit [173]

An electronic handheld dynamometer to measure grip
strength (finger flexion force).

Jamar Dynamometer [168]

An hydraulic handheld dynamometer to measure grip
strength (finger flexion force).

Disabilities of the Arm, Shoulder,
and Hand (DASH) [169]

Assesses the disability of the upper extremity and can
monitor change in symptoms and upper limb function
over time.

Patient Specific Functional Scale
(PSFS) [166]

Patients identify up to five important activities they are
having difficulty with as a result of their disease.

Scleroderma Health Assessment
Questionnaire SHAQ
[160,164,171]

Self-reported questionnaire assessing disability and
function, adopted for SSc with VASs for pain, DU, RP,
breathing, and GI problems

Cochin Hand Function Test
(CHFT) [161,171,172] (aka
Duruoz Hand Index) Abilhand
[171,172,174]

18-item questionnaire measuring manual ability of daily
activities.
26-item questionnaire assessing level of difficulty of
upper extremity tasks.

Hand Mobility in Scleroderma
(HAMIS) [170]

9 items designed to measure all movements assessed in
an ordinary ROM-measured hand test.

Hand Anatomic Index (HAI)
[162,163]

Measurement of open hand span minus closed hand
span/lateral height of hand.

Hand Function Index (HFI) [175]

9 items of the Keital Functional Test that assess global
hand and wrist mobility.

Mouth Handicap in Systemic
Sclerosis Scale (MHISS) [149]

12-item scale representing impairment related to mouth
opening, sicca, and esthetic concerns.

Muscle
strength

Author Manuscript

Aerobic
capacity

Author Manuscript

Upper
Extremity
Activity
limitation

Hand function
and motion

Author Manuscript

Mouth
Function

Comments

Functional capacity test for
patients with
cardiopulmonary problems.

Requires less than 1 min.

Abbreviations: DUs, digital ulcers; GI, gastrointestinal; ROM, range of motion; RP, Raynaud's phenomenon; Sicca, oral dryness; and VAS: visual
analog scale.
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Table 10

Author Manuscript

Potential exercise enhancing qualities of water-based exercise and therapies.
Possible effects of aquatic exercise in general populations [271–273]
Improved domains

HRQoL
Pain
Fatigue
Muscle function, strength, and endurance
Aerobic capacity
Physical function
Range of motion
Stiffness
Muscle spasm
Circulation

Author Manuscript

Reduced disease activity in some Inflammatory diseases
Safety

Water properties minimize the risk of injury/re-injury
Buoyancy and immersion anti-gravity offloading effects provide protective measure
Advisement on pacing to protect against unintended overexertion

Tolerability

Increase ability to focus body movement
Stretching more tolerable
Increased exercise duration
Increased exercise intensity

Patient-centered
considerations
Skin

Rinsing after chlorinated and salted water
Moisturizing skin post-exercise to minimize skin dryness/irritation

Author Manuscript

Temperature

Aqueous and ambient temperatures facility and changing room require assurance of warmth

Logistical feasibility and
patient effort

Planning time, energy, and assistance for pre/post preparations. Patients report feeling more exhausted by
logistics of clothes change than the exercise, and state exercise benefit is worth it but needs to be addressed.
Consider attendants to assist

Mobility

Support for descending/ascending into pool

Abbreviations: AROM, active range of motion and HRQoL, health-related quality of life.

Author Manuscript
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Table 11

Author Manuscript

Preliminary research agenda for the investigation of exercise inSSc as advocated by The Global Fellowship on

Rehabilitation and Exercise in Systemic Sclerosis (G-FoRSS)
QUALITATIVE
INVESTIGATIONS

Patient experiences of exercises prior to and concurrent with SSc diagnosis:
Personal feelings before SSc diagnosis
Activity profile
Observation of sweating in SSc
Type of exercises
Pleasure
Preferential time of day and frequency
Exercise adherence to sustain benefit over time
Home-based versus hospital-based settings for exercise
Patient perceived impact of exercise on:

Author Manuscript

SSc Manifestation Domains:
Raynaud, circulation, and sustaining core warmth
Wound healing
Calcinosis
Lung symptoms
Gastrointestinal: SICCA, bloating, and constipation
Muscle function
Articular function
Sexual function, e.g., erectile dysfunction improvement after aerobic exercise
Symptom Domains:
Dyspnea
Cough

Author Manuscript

Pain
Fatigue
Sleep
HRQoL Domains:
Body Image and Self-esteem
Well-being and vitality
Depression/Anxiety
Meaningful activities
Worker productivity/performance
Body perception
Patient perceptions of engaging in exercise:
Fears and worries

Author Manuscript

Hopes, goals, and benefits
Benefits of individual or group PT led “SSc School on Exercise"
Home-based versus hospital-based settings for exercise

Goals are to fulfil anticipated benefits and provide knowledge to address concerns
Patient-perceived barriers/hindrances to initiating and to sustaining exercise practice:
Logistical management (oxygen, changing clothes/shoes, physical, and work)

Best Pract Res Clin Rheumatol. Author manuscript; available in PMC 2022 September 01.

Pettersson et al.

Page 58

Time restraints (work and family)
Time management/prioritizations

Author Manuscript

Climate
Access to pleasurable self-directed exercise
Access to home or hospital-based exercise
Modality of delivery:
Digital/Print
Audio/Visual Recording
Community/collective learning
Community/collective exercise
Combined approaches
Medication side effects
Presence of pain

Author Manuscript

QUANTITATIVE
INVESTIGATIONS

Characterizing FITT in both aerobic and resistance exercise to target circulatory, antiinflammatory, and respiratory
effects.
Best submaximal exercise testing method in SSc – with special focus on different degrees of lung involvement
Priority systemic exercise types (e.g., resistance, aerobic, etc.) in SSc
As a general approach to SSc
With and without lung/heart involvement:
- In severe pulmonary disease
- Across varying degrees of lung involvement?
- In combined PH and ILD
- Respiratory training – inspiratory muscle training and/or positive expiratory pressure
With further definition in land- and water-based applications
The use of minimally invasive muscle biopsies to evaluate response to exercise
Home-based versus hospital-based settings for exercise
Effects of exercise on:

Author Manuscript

Raynaud phenomenon
Sexual function
Circulatory and hemodynamic effects
Worker productivity/performance
Serum and histological biomarkers:
Muscle tissue mRNA expression of inflammatory and fibrotic pathways
Inflammatory serum biomarkers
Angiogenesis
NT-Pro-BNP and Uric acid
SSc Manifestation Domains:
Raynaud, circulation, and sustaining core warmth
Wound-healing

Author Manuscript

Calcinosis
Skin tightening
Gastrointestinal: sicca (oral dryness), bloating, and constipation
Muscle function
Articular function: strength and AROM/PROM
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Symptom Domains:
Dyspnea

Author Manuscript

Cough
Pain
Fatigue
Sleep
HRQoL Domains:
Body Image and Self-esteem
Well-being and vitality
Depression/Anxiety
Meaningful activities and participation
Self-perception of general health
Effects of stretching/AROM/PROM (as above)
HANDS:

Optimal treatment protocols

Author Manuscript

Comparative efficacy of different delivery methods
Hand function and joint motion
Optimal time in disease progression to emphasize hand exercises
Impact of hand exercise on:
Raynaud
Digital ulcers/Wound healing/Calcinosis/Infection rate
Contracture development/improvement
Skin tightening
Manual dexterity
Worker productivity/performance
Self-esteem
OROFACIAL:

Impact of orofacial exercises on:

Author Manuscript

Prevention or delay of facial changes in people with SSc
Dental/oral hygiene
Dental/palatal structure changes
Oral aperture: diameter and mobility
Changes in lip thickness
Nutritional intake/status
Salivary production
Well-being/self-esteem
Progression of telangiectases
Sauna as adjuvant to exercise

Author Manuscript

HEALTH
ECONOMIC
PERSPECTIVE

Cost-efficiency of supervised or educational interventions for patients
Cost return on PT/OT/RT supervised structured exercise retreats in warmer climates to develop exercise safety and
efficacy knowledge, intensify patient interest, and empowerment, and explore variance of self-directed exercise
Patient costs related to supervised or patient-directed exercise interventions
Hospital visits and need of medical treatment

SUSTAINABILITY

Patient general knowledge regarding exercise programs and continuance
Patient-reported experiences of successful maintenance prior to and concurrent with SSc diagnosis
Patient perceptions of potential external strategies to sustain exercise
Patient perceptions of self-regulating strategies to sustain exercise
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SAFETY

Screening for safety

Author Manuscript

Screening for individually tailored safety modifications – baseline assessment – to tailor exercise and safety measures
to the individual
Range of safe parameters in:
- non-cardiopulmonary involvement
- ILD, PH or combined ILD/PH or heart failure
- patients with other vital organ involvement
Self-monitoring devices e.g., oximetry
- Guidance on efficient use
- Distress related to use
PROGRAMMATIC
EXERCISE
DESIGN

Intensity
Session duration
Frequency
Escalation protocols

Author Manuscript

Safety assessments
Equipment
General vs. SSc Manifestation Targeted
Transition to Patient-managed continuance
INVESTIGATION
OF EXERCISE
TYPES and
QUALITIES

Patient Preference/Aspirations
Patient Experience
Types Deconstructed by Programmatic Components
Resistance
Aerobic
Singing
Water-based
Yoga

Author Manuscript

Balance
Combined approaches with borrowed elements to maximize benefit
PATIENT SELF
ASSESSMENT

Patient perceptions and patient experience of utility
Patient experience of self-governance
Track own metrics – authentic supported self-management
Patient as their own control
Metrics that are personalized to patient context
- Patient-specific activity profile
- Mouth diameter card
- Hand tracings for extension
- Duration, Intensity, and Load of selected exercise
- VAS for fatigue, pain, RP, and muscle tiredness and dyspnea

Author Manuscript

- Patient-Specific Functional Scale (PSFS)
- VAS for patient-selected goal activities
TRIAL DESIGN

Relative importance of cohort assembly
SSc criteria confirmation
Targeted manifestation (ILD, PH, DU, etc)
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Phenotype (e.g., sine, dcSSc, and lcSSc)
Degree of lung involvement (e.g., No – Mild vs Moderate – End-stage)

Author Manuscript

Acceptable blinding and randomization procedures Optimal study duration for efficacy
Harmonized patient support/check-ins across trials
Standardized adherence monitoring
Safety assessment
Procedures for selecting primary, co-primary, secondary, and exploratory endpoints
Standardized components of warm-up, cool-down, and stretching of muscles/skin
Qualitative collection of patient experience data related to intervention and trial
Global consensus on harmonization of outcome measures
Promote interstudy comparative potential
Ensure COSMIN thresholds of reliable performance and patient-reported outcome measures
- Identification of optimal existing outcome measures
- New instrument development or modification where needed e.g., Activity Profile

Author Manuscript

- Acceptability to patients
- Defining interval outcome measure assessment
- Define best practice of pulse oximetry during exercise
MODALITY

How people learn
Hard copy of learning resources versus web-based resources
What impacts preferred modalities of learning and participation – age, gender, etc.
Inherent challenges in home-based / telehealth /virtual sessions:
- measuring range of motion e.g. joints of hands
- predicting in home safety e.g. tripping hazards
Use of apps, pictures, and videos to collect outcome data.

Author Manuscript

Abbreviations: AROM, active range of motion; dcSSc, diffuse cutaneous SSc; COSMIN, Consensus-based Standards for the selection of health
Measurement Instruments; DU, digital ulcers; HRQoL, health-related quality of life; ILD, interstitial lung disease; lcSSc, limited cutaneous SSc;
mRNA, messenger ribonucleic acid; NT-pro-BNP, N-terminal prohormone ofbrain natriuretic peptide; OT, occupational therapist; PH, pulmonary
hypertension; PROM, passive range of motion; PT, physiotherapist; RT, respiratory therapist; and VAS, visual analog scale.

Author Manuscript
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